Bluejay Diagnostics, Inc. filed its 10-K on Mar 20, 2023 for the period ending Dec 31, 2022. In this report its auditor, Wolf & Company, P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.433 USD | -6.88% | -18.30% | -64.51% |
05-31 | Bluejay Diagnostics, Inc. announced a financing transaction | CI |
05-15 | Bluejay Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-64.51% | 1.16M | |
-41.97% | 7.92B | |
+5.99% | 3.51B | |
-4.31% | 2.18B | |
-21.69% | 1.97B | |
-24.94% | 1.58B | |
+31.45% | 1.14B | |
+26.75% | 792M | |
-9.83% | 690M | |
-26.33% | 532M |
- Stock Market
- Equities
- BJDX Stock
- News Bluejay Diagnostics, Inc.
- Bluejay Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt